Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Trimeris Inc (TRMS) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Trimeris Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 911326.
Total stock buying since 2014: $188,380,000.
Total stock sales since 2014: $29,810,422.
Total stock option exercises since 2014: $7,994,681.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2015 | 2,000,000 | $188,380,000 | 166,514 | $18,233,234 | 146,514 | $4,772,454 |
| 2014 | 0 | $0 | 141,472 | $11,577,188 | 171,222 | $3,222,227 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2015-06 | 0 | $0 | 12,916 | $2,779,781 | 12,916 | $767,339 |
| 2015-05 | 0 | $0 | 1,666 | $345,671 | 1,666 | $81,534 |
| 2015-04 | 0 | $0 | 102,135 | $10,092,172 | 82,135 | $2,720,489 |
| 2015-03 | 0 | $0 | 7,500 | $772,672 | 7,500 | $305,550 |
| 2015-02 | 0 | $0 | 42,297 | $4,242,938 | 42,297 | $897,542 |
| 2015-01 | 2,000,000 | $188,380,000 | 0 | $0 | 0 | $0 |
| 2014-12 | 0 | $0 | 56,100 | $4,960,229 | 56,100 | $545,685 |
| 2014-10 | 0 | $0 | 25,404 | $2,034,839 | 25,404 | $313,739 |
| 2014-09 | 0 | $0 | 24,369 | $1,647,569 | 24,369 | $355,440 |
| 2014-06 | 0 | $0 | 25,672 | $2,114,184 | 55,422 | $1,990,488 |
| 2014-05 | 0 | $0 | 9,927 | $820,367 | 9,927 | $16,875 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2015-06-08 | Williams Glen (SVP, Technical Operations) | Sale | 12,916 | 215.22 | 2,779,781 |
| 2015-06-08 | Williams Glen (SVP, Technical Operations) | Option Ex | 12,916 | 59.41 | 767,339 |
| 2015-05-06 | Williams Glen (SVP, Technical Operations) | Sale | 1,666 | 207.49 | 345,671 |
| 2015-05-06 | Williams Glen (SVP, Technical Operations) | Option Ex | 1,666 | 48.94 | 81,534 |
| 2015-04-27 | Quinn Anthony (EVP, CMO & Head of R&D) | Sale | 10,000 | 110.00 | 1,100,000 |
| 2015-04-27 | Quinn Anthony (EVP, CMO & Head of R&D) | Option Ex | 10,000 | 1.70 | 17,000 |
| 2015-04-21 | Quinn Anthony (EVP, CMO & Head of R&D) | Sale | 10,000 | 108.00 | 1,080,000 |
| 2015-04-15 | Quinn Anthony (EVP, CMO & Head of R&D) | Sale | 10,000 | 105.00 | 1,050,000 |
| 2015-04-15 | Quinn Anthony (EVP, CMO & Head of R&D) | Option Ex | 10,000 | 40.74 | 407,400 |
| 2015-04-08 | Williams Glen (SVP, Technical Operations) | Sale | 39,863 | 96.08 | 3,830,037 |
| 2015-04-08 | Williams Glen (SVP, Technical Operations) | Option Ex | 39,863 | 48.94 | 1,950,895 |
| 2015-04-07 | Williams Glen (SVP, Technical Operations) | Sale | 2,769 | 96.04 | 265,934 |
| 2015-04-07 | Williams Glen (SVP, Technical Operations) | Option Ex | 2,769 | 40.32 | 111,646 |
| 2015-04-06 | Quinn Anthony (EVP, CMO & Head of R&D) | Sale | 29,503 | 93.76 | 2,766,201 |
| 2015-04-06 | Quinn Anthony (EVP, CMO & Head of R&D) | Option Ex | 19,503 | 11.97 | 233,548 |
| 2015-03-11 | Heberlig Chris (SVP, Finance and Business Ops.) | Sale | 7,500 | 103.02 | 772,672 |
| 2015-03-11 | Heberlig Chris (SVP, Finance and Business Ops.) | Option Ex | 7,500 | 40.74 | 305,550 |
| 2015-02-17 | Boess Carsten (SVP, Chief Financial Officer) | Sale | 42,297 | 100.31 | 4,242,938 |
| 2015-02-17 | Boess Carsten (SVP, Chief Financial Officer) | Option Ex | 42,297 | 21.22 | 897,542 |
| 2015-01-07 | Baker Bros. Advisors (gp) Llc (Director) | Buy | 1,000,000 | 94.19 | 94,190,000 |
| 2015-01-07 | Baker Felix (Director) | Buy | 1,000,000 | 94.19 | 94,190,000 |
| 2014-12-29 | Heberlig Chris (Group Vice President, Finance) | Sale | 6,100 | 91.59 | 558,729 |
| 2014-12-29 | Heberlig Chris (Group Vice President, Finance) | Option Ex | 6,100 | 12.35 | 75,335 |
| 2014-12-17 | Patel Sanj K (President & CEO) | Sale | 50,000 | 88.03 | 4,401,500 |
| 2014-12-17 | Patel Sanj K (President & CEO) | Option Ex | 50,000 | 9.41 | 470,350 |
| 2014-10-30 | Boess Carsten (SVP, Chief Financial Officer) | Sale | 22,904 | 80.11 | 1,834,839 |
| 2014-10-30 | Boess Carsten (SVP, Chief Financial Officer) | Option Ex | 22,904 | 12.35 | 282,864 |
| 2014-10-28 | Boess Carsten (SVP, Chief Financial Officer) | Sale | 2,500 | 80.00 | 200,000 |
| 2014-10-28 | Boess Carsten (SVP, Chief Financial Officer) | Option Ex | 2,500 | 12.35 | 30,875 |
| 2014-09-19 | Goldberg Mark Alan (EVP, Medical & Reg. Strategy) | Sale | 790 | 65.24 | 51,539 |
| 2014-09-19 | Goldberg Mark Alan (EVP, Medical & Reg. Strategy) | Option Ex | 790 | 8.73 | 6,896 |
| 2014-09-17 | Goldberg Mark Alan (EVP, Medical & Reg. Strategy) | Sale | 4,200 | 65.06 | 273,252 |
| 2014-09-17 | Goldberg Mark Alan (EVP, Medical & Reg. Strategy) | Option Ex | 4,200 | 8.73 | 36,666 |
| 2014-09-16 | Goldberg Mark Alan (EVP, Medical & Reg. Strategy) | Sale | 9,379 | 65.01 | 609,728 |
| 2014-09-16 | Goldberg Mark Alan (EVP, Medical & Reg. Strategy) | Option Ex | 9,379 | 8.73 | 81,878 |
| 2014-09-02 | Quinn Anthony (EVP, CMO & Head of R&D) | Sale | 10,000 | 71.31 | 713,050 |
| 2014-09-02 | Quinn Anthony (EVP, CMO & Head of R&D) | Option Ex | 10,000 | 23.00 | 230,000 |
| 2014-06-25 | Williams Glen (SVP, Technical Operations) | Sale | 700 | 108.02 | 75,614 |
| 2014-06-25 | Williams Glen (SVP, Technical Operations) | Option Ex | 700 | 48.94 | 34,258 |
| 2014-06-20 | Quart Barry D | Sale | 1,375 | 100.00 | 137,500 |
| 2014-06-20 | Quart Barry D | Option Ex | 1,375 | 25.00 | 34,375 |
| 2014-06-20 | Baker Bros. Advisors Lp (Director) | Option Ex | 29,750 | 60.45 | 1,798,387 |
| 2014-06-17 | Quart Barry D | Sale | 1,000 | 90.00 | 90,000 |
| 2014-06-17 | Quart Barry D | Option Ex | 1,000 | 23.95 | 23,950 |
| 2014-06-12 | Quart Barry D | Sale | 1,000 | 83.31 | 83,310 |
| 2014-06-12 | Quart Barry D | Option Ex | 1,000 | 23.00 | 23,000 |
| 2014-06-11 | Goldberg Mark Alan (EVP, Medical & Reg. Strategy) | Sale | 21,597 | 80.00 | 1,727,760 |
| 2014-06-11 | Goldberg Mark Alan (EVP, Medical & Reg. Strategy) | Option Ex | 21,597 | 3.54 | 76,518 |
| 2014-05-16 | Boess Carsten (SVP, Chief Financial Officer) | Sale | 9,927 | 82.64 | 820,367 |
| 2014-05-16 | Boess Carsten (SVP, Chief Financial Officer) | Option Ex | 9,927 | 1.70 | 16,875 |
Insider trading activities including stock purchases, stock sales, and option exercises of TRMS listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Trimeris Inc (symbol TRMS, CIK number 911326) see the Securities and Exchange Commission (SEC) website.